Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced the completion of the first tranche of corporate bonds (T1 Corporate Bonds) by its wholly-owned subsidiary, China Universal Leasing Co., Ltd., on 5 February 2026.

According to the announcement, the total principal amount of the T1 Corporate Bonds is RMB1 billion, with a basic term of five years starting from 5 February 2026 and a fixed interest rate of 2.12%. At the end of the third and fourth year, the issuer holds a repurchase option and a coupon rate adjustment option, while investors have a sell-back option. The issue price is RMB100 per bond, equivalent to 100% of the principal value.